Studies involving DXA      

Filter by:
Data set Procedure What's in this data set Panel Sex Age (weeks) Year
Ackert1 DXA Body mass, fat mass, lean mass, bone mineral density and content, body area, bone area. Aging study, 6mo, 12mo, 20mo. inbred   (32) both 26, 52, 87 wks 2008
Attie2 DXA
with high-fat high-sucrose diet 		Bone mineral density. Isolated tibia. DO population both 4-26wks 2018
CGDpheno1 DXA Body mass, fat mass, lean mass, bone mineral density. inbred w/CC8   (72) both 10-13wks 2009
CGDpheno2 DXA Body mass, fat mass, lean mass, bone mineral density. Variation over time of controls. one strain: C57BL/6J both 2009
CGDpheno3 DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. CC diallel w/par   (62) both 8-16wks 2012
Churchill1 DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. F1 8way   (63) both 7-8wks 2004
Donahue1 DXA Body mass, fat mass, lean mass, bone mineral density and content, craniofacial dimensions. inbred w/CC7   (30) both 15-16wks 2002
Donahue16 DXA Body mass, fat mass, bone mineral density. B6.A consomic w/par   (23) both 24-29wks 2012
Donahue2 DXA Femur bone mineral density and content, thigh cross sectional areas. inbred   (10) both 16wks 2004
Eumorphia2 DXA Body mass, fat mass, lean mass, bone mineral density and content. inbred   (5) both 12, 24, 52 wks 2008
GMC18 DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. inbred w/CC8   (8) both 17-18wks 2020
HMDPpheno1 DXA Bone mineral density (whole body, femur, spine). HMDP   (96) m 16wks 2011
ITP1 DXA
with (R/S)-1,3-butanediol, 17-a-estradiol, 17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride, 2-(2-Hydroxyphenyl)benzoxazole, 3-(3-hydroxybenzyl)-5-methylbenzo[d]oxazol-2(3H)-one, 4-OH-a-phenyl-N-tert-butyl nitrone, 4-phenylbutyrate, acarbose, aspirin, astaxanthin, b-guanidinopropionic acid, caffeic acid phenethyl ester, canagliflozin, captopril, candesartan cilexetil, curcumin, dimethyl fumarate, enalapril, fisetin, fish oil, geranylgeranyl acetone, glycine, green tea extract, INT-767 FXR/TGR5 agonist, inulin, L-Leucine, meclizine, medium-chain triglyceride, metformin, metformin plus rapamycin, methylene blue, minocycline, MitoQ, mycophenolic acid, nicotinamide riboside, nitroflurbiprofen, nordihydroguaiaretic acid, oxaloacetic acid, PB125, protandim, rapamycin, rapamycin plus acarbose, resveratrol, SG1002, simvastatin, sulindac, syringaresinol, TM5441, ursodeoxycholic acid, ursolic acid, 16-a-hydroxyestriol, 2,4-dinitrophenol, a-Ketoglutarate, Hydralazine, Nebivolol, Sodium thiosulfate 		Body composition. Body mass, fat mass, lean mass, water content. Intervention vs. controls. UM-HET3 population both various 2004-2024
JaxCC1 DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. CC   (18) both various 2018
JaxKOMP-EAP DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. KOMP both 8-18wks 2021
JaxKOMP-LAP DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. KOMP both 66-81wks 2021
Jaxpheno1 DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. inbred   (11) both 8, 16 wks 2006
Jaxwest1 DXA Body mass, fat mass, lean mass, bone mineral density and content (whole body, femur, spine). inbred   (7) both 8-14wks 2003
Naggert1 DXA
with high-fat diet 		Body mass, fat mass, lean mass, bone mineral density and content after 8wks on high-fat diet. inbred w/CC7   (43) both 5, 21 wks 2003
Reed2 DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. High-fat diet vs. control. Two age cohorts. B6.129 and 129.B6 consomic w/par   (9) both 26wks 2015
Schonfeld1 DXA Fat mass. inbred   (11) both 8-10wks 2005
Svenson4 DXA Body mass, fat mass, lean mass, bone mineral density and content. B6.PWD consomic w/par   (28) both 16wks 2006
Tordoff3 DXA Body mass, fat mass, lean mass, bone mineral density and content. inbred w/CC7   (40) both 9-15wks 2002